CAULI, ALBERTO
 Distribuzione geografica
Continente #
EU - Europa 148.224
NA - Nord America 8.505
AS - Asia 1.113
OC - Oceania 21
AF - Africa 19
SA - Sud America 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 157.893
Nazione #
IT - Italia 146.098
US - Stati Uniti d'America 8.436
UA - Ucraina 734
CN - Cina 692
SE - Svezia 544
DE - Germania 227
FI - Finlandia 226
GB - Regno Unito 173
VN - Vietnam 122
SG - Singapore 71
CA - Canada 67
FR - Francia 66
IN - India 46
JP - Giappone 35
HK - Hong Kong 28
TR - Turchia 28
BE - Belgio 27
NL - Olanda 21
IR - Iran 19
AU - Australia 18
IL - Israele 18
ES - Italia 15
RU - Federazione Russa 15
IE - Irlanda 13
KR - Corea 13
PL - Polonia 12
IQ - Iraq 11
EG - Egitto 10
ID - Indonesia 8
LT - Lituania 8
GR - Grecia 7
CZ - Repubblica Ceca 6
EC - Ecuador 6
JO - Giordania 5
RO - Romania 5
PH - Filippine 4
PT - Portogallo 4
AT - Austria 3
BG - Bulgaria 3
HR - Croazia 3
MD - Moldavia 3
NZ - Nuova Zelanda 3
RS - Serbia 3
TN - Tunisia 3
TW - Taiwan 3
BD - Bangladesh 2
CH - Svizzera 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
LU - Lussemburgo 2
PK - Pakistan 2
TH - Thailandia 2
A1 - Anonimo 1
AL - Albania 1
BN - Brunei Darussalam 1
BR - Brasile 1
CL - Cile 1
ET - Etiopia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
ZA - Sudafrica 1
Totale 157.893
Città #
Cagliari 145.445
Fairfield 1.221
Woodbridge 1.034
Houston 654
Chandler 651
Ashburn 543
Wilmington 520
Ann Arbor 479
Seattle 438
Nyköping 412
Cambridge 393
Jacksonville 389
Dearborn 237
Boardman 179
Boston 144
Nanjing 141
Dong Ket 118
Helsinki 106
Shanghai 102
San Diego 92
Beijing 84
Rome 70
Redwood City 62
Shenyang 48
Toronto 47
Nanchang 45
Milan 44
London 38
New York 38
Hebei 37
Mountain View 29
Guangzhou 27
Sassari 26
Jiaxing 25
Phoenix 25
Hong Kong 24
Tianjin 24
Changsha 22
Auburn Hills 21
Falls Church 21
Los Angeles 20
Brussels 19
Hefei 19
Norwalk 18
Orange 18
Pune 16
San Mateo 16
Washington 16
Ningbo 14
Verona 13
Jinan 12
Tokyo 12
Amsterdam 11
Naples 11
Bat Yam 10
Chicago 10
Dublin 10
Kunming 10
Leawood 10
Zhengzhou 10
Augusta 9
Detroit 9
Sivas 9
Turin 9
Brisbane 8
Singapore 8
Ardabil 7
Borås 7
Hounslow 7
Mumbai 7
Paris 7
Walnut 7
Baghdad 6
Guayaquil 6
Hyderabad 6
Indiana 6
Kiryat Ono 6
Laurel 6
Nuoro 6
Padova 6
Redmond 6
Amman 5
Bari 5
Duncan 5
Kaunas 5
Kilburn 5
Sestu 5
Anguillara 4
Catania 4
Fuzhou 4
Halifax 4
Hangzhou 4
Istanbul 4
Jakarta 4
Karbala 4
Quartu Sant'elena 4
Renton 4
Rockville 4
Taizhou 4
Tertenìa 4
Totale 154.560
Nome #
Physician's global assessment in psoriatic arthritis: A multicenter GRAPPA study 2.522
Expression analysis of HLA-E and NKG2A and NKG2C receptors points at a role for natural killer function in ankylosing spondylitis 2.434
AIF-1 gene does not confer susceptibility to Behçet's disease: Analysis of extended haplotypes in Sardinian population 2.406
Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001-2012 2.334
Population-based analysis of hospitalizations for patients with systemic sclerosis in a West-European region over the period 2001–2012 2.274
null 2.245
Patient Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA and OMERACT Study 2.190
Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus 2.123
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study 2.120
Defective cerebral gamma-aminobutyric acid-A receptor density in patients with systemic lupus erythematosus and central nervous system involvement. An observational study 2.089
Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus 2.049
An allelic variant in the intergenic region between ERAP1 and ERAP2 correlates with an inverse expression of the two genes 1.980
Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: An alternative to standard of care 1.970
Demyelinating syndrome in SLE encompasses different subtypes: Do we need new classification criteria? Pooled results from systematic literature review and monocentric cohort analysis 1.961
Killer-cell immunoglobulin-like receptors (KIR) and HLA-class I heavy chains in ankylosing spondylitis 1.940
Polymyalgia rheumatica: an autoinflammatory disorder? 1.932
Molecular modifications induced by mud-bath therapy in patients with osteoarthritis 1.889
Spa therapy induces clinical improvement and protein changes in patients with chronic back pain 1.882
Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series 1.868
FRI0357 DRUG-INDUCED REMISSION AND SUBCLINICAL ACTIVITY IN PSORIATIC ARTHRITIS: TRANSCRIPTIONAL PROFILING TO CHARACTERIZE THE DISEASE STATE 1.864
Prognostic impact of coronary microcirculation abnormalities in systemic sclerosis: a prospective study to evaluate the role of non-invasive tests 1.810
Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review 1.806
Protective effects of hydroxychloroquine against accelerated atherosclerosis in systemic lupus erythematosus 1.802
PET/CT scan revealing active idiopathic inflammatory myopathy with normal serum sarcoplasmic enzymes levels 1.800
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09 1.792
null 1.791
Switch or swap strategy in rheumatoid arthritis patients failing TNF inhibitors? Results of a modified Italian Expert Consensus 1.788
The rs75862629 minor allele in the endoplasmic reticulum aminopeptidases intergenic region affects human leucocyte antigen B27 expression and protects from ankylosing spondylitis in Sardinia 1.781
Biologics-induced autoimmune renal disorders in chronic inflammatory rheumatic diseases: Systematic literature review and analysis of a monocentric cohort 1.752
Susceptibility to ankylosing spondylitis but not disease outcome is influenced by the level of HLA-B27 expression, which shows moderate variability over time 1.734
Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet's Syndrome 1.731
Pachidermoperiostosis as a cause of massive joint effusion with polyarticular involvement mimicking juvenile idiopathic arthritis: A case report 1.707
The ankylosing spondylitis-associated HLA-B*2705 presents a B*0702-restricted EBV epitope and sustains the clonal amplification of cytotoxic T cells in patients 1.701
Comment on: Auto-antibodies to double-stranded DNA as biomarker in systemic lupus erythematosus: comparison of different assays during quiescent and active disease 1.700
Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis) 1.675
Ankylosing spondylitis: A trade off of HLA-B27, ERAP, and pathogen interconnections? Focus on Sardinia 1.674
Rituximab treatment for 'rhupus syndrome': clinical and power-Doppler ultrasonographic monitoring of response. A longitudinal pilot study 1.592
null 1.562
Re: Ultrasound Findings on Hands and Wrists of Patients with Systemic Lupus Erythematosus: Relationship with Physical Examination 1.554
Unusual Placement of an EBV Epitope into the Groove of the Ankylosing Spondylitis-Associated HLA-B27 Allele Allows CD8+ T Cell Activation 1.514
null 1.431
New approaches in tumor necrosis factor antagonism for the treatment of psoriatic arthritis: certolizumab pegol 1.399
ENDODONTIC RETREATMENT AS AN ALTERNATIVE TO SURGICAL THERAPY IN PATIENTS TREATED WITH BIPHOSPHONATES: A CASE REPORT 1.376
Long-term costs and outcomes in psoriatic arthritis patients not responding to conventional therapy treated with tumour necrosis factor inhibitors: the extension of the Psoriatic Arthritis Cost Evaluation (PACE) study 1.325
Genetics of seronegative spondyloarthritis, susceptibility and aetiopathogenesis: A single centre experience 1.272
Gene expression profiling of monozygotic twins affected by psoriatic arthritis 1.268
Development and preliminary validation of the Behçet's syndrome Overall Damage Index (BODI) 1.256
Treatment target in newly diagnosed systemic lupus erythematosus: The association of lupus low disease activity state and remission with lower accrual of early damage 1.247
Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology 1.195
Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patients 1.191
Active elderly and health—can moderate exercise improve health and wellbeing in older adults? Protocol for a randomized controlled trial 1.117
null 1.111
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients 1.101
The growing role of cardiac magnetic resonance imagin in assessment and follow-up of pulmonary arterial hypertension associated with systemic sclerosis 1.093
Circulating CD8+CD28(null) T cytotoxic cells in polymyositis - a possible biomarker? Comment on the article by Pandya et al. 1.088
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 1.022
Patient Assessments of Skin, Joint, and Nail Disease Activity in Psoriatic Arthritis Reply 963
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project) 952
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 929
null 902
The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNF-alpha agents in axial spondyloarthritis 866
Proceedings of the GRAPPA 2016 retreat 840
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis 837
null 831
Updated guidelines for the management of axial disease in psoriatic arthritis 823
Hemarthrosis as acute presentation of acquired hemophilia in a patient with systemic lupus erythematosus: successful treatment and long-lasting remission 818
Current smoking predicts inadequate response to methotrexate monotherapy in rheumatoid arthritis patients naïve to DMARDs: Results from a retrospective cohort study 770
Liver involvement in systemic lupus erythematosus: incidence, clinical course and outcome of lupus hepatitis 757
Psoriatic disease: Update on traditional disease-modifying antirheumatic drugs 744
HLA-B*2709 and lack of susceptibility to sacroiliitis: further support from the clinic 734
Coronary atherosclerosis using computed tomography coronary angiography in patients with systemic sclerosis: comment on the article by Mok et al 732
Two different clinical subsets of lupus hepatitis exist. Mimicking primary autoimmune liver diseases or part of their spectrum? 714
Familial chilblain and late contractural arachnodactyly: A novel association? 703
Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study 700
null 691
Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis 675
Evaluation of cardiac functional abnormalities in systemic sclerosis by dobutamine stress echocardiography. A myocardial echostress scleroderma pattern 673
A functional polymorphism of the vasoactive intestinal peptide receptor 1 gene correlates with the presence of HLA-B*2705 in Sardinia 661
Genetics of psoriasis and psoriatic arthritis 655
null 622
Moderate exercise improves cognitive function in healthy elderly people: results of a randomized controlled trial 620
Psoriatic arthritis: genetics and pathogenesis 619
HLA-E gene polymorphism associates with ankylosing spondylitis in Sardinia 578
The interplay between the geographic distribution of HLA-B27 alleles and their role in infectious and autoimmune diseases: A unifying hypothesis 575
Targeted Therapies in Axial Psoriatic Arthritis 570
Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease 567
Absence of epicardial coronary stenosis in patients with systemic sclerosis and severe impairment of coronary flow reserve 566
Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) 562
null 560
Whole-body MRI in rheumatology: Major advances and future perspectives 559
Psoriatic Arthritis and Psoriasis Projects in Italy: A Report from the GRAPPA 2011 Annual Meeting 547
Primary antiphospholipid syndrome with mesenteric venous thrombosis presenting with intestinal infarction: a case description 543
Can synovial pathobiology integrate with current clinical and imaging prediction models to achieve personalized health care in rheumatoid arthritis? 541
Bone mineral density in women on long-term mud-bath therapy in a Salus per Aquam (SPA) environment 537
Telemedicine in rheumatology: high specificity and sensitivity of follow-up virtual video consultations during COVID-19 pandemic 536
Biologics and Targeted Synthetic Drugs Can Induce Immune-Mediated Glomerular Disorders in Patients with Rheumatic Diseases: An Updated Systematic Literature Review 535
Bleomicin induced scleroderma: report of a case with a chronic course rather than the typical acute/subacute self-limiting form 522
HLA DRB1*01 and DRB1*04 alleles in Sardinian rheumatoid arthritis patiens 515
Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus 501
The definition and measurement of axial psoriatic arthritis 495
Totale 125.470
Categoria #
all - tutte 205.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 205.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.628 0 0 0 0 0 0 0 0 0 422 658 548
2019/202030.671 1.555 802 185 656 11.439 8.370 3.907 983 668 520 524 1.062
2020/202141.777 1.302 1.435 1.638 12.165 8.700 4.829 3.977 2.068 816 1.633 1.733 1.481
2021/202211.235 922 840 574 479 785 961 619 538 1.265 997 1.717 1.538
2022/202316.914 1.680 1.998 1.560 1.373 1.594 1.757 961 1.586 1.085 1.157 1.360 803
2023/202424.765 1.238 1.194 1.008 1.812 2.655 3.806 3.837 6.469 1.222 1.524 0 0
Totale 158.714